MANAGING PAIN MANAGEMENT- A PUBLIC HEALTH CHALLENGE
Author(s)
Bertin P1, Auges M2, Rahhali N2, Taieb C21Comité LUtte contre la Douleur, Limoges, France, 2PFSA, Boulogne Billancourt, France
OBJECTIVES: A daily assessment of the speed of action and effectiveness of treatment of a combination of paracetamol and codeine in patients suffering from intense pain, which has progressed since less than 7 days. METHODS: A multi-centre longitudinal observational prospective study carried out in metropolitan France using data collected by general practitioners who agreed to participate.RESULTS: A total of 804 patients treated by a paracetamol-codeine combination (600mg/50mg and 400mg/20mg) were included. The severity of pain measured at inclusion using a visual numeric scale was 7 ± 1.3. The severity of pain measured after half a day of treatment was 5.29 ± 1.87 and 5.65 ± 1.85 at the end of the first 24 hours of treatment. A significant improvement in pain was observed from the first half-day (p<0.001). The severity of pain on the 2nd, 4th and 7th evenings was respectively 4.09 ± 1.87; 2.74 ± 1.8 and 1.78 ± 1.7. On D1, 70.8% declared treatment to be effective, 62.56% were satisfied with their treatment and 80.5% did not observe any side effects to the treatment. On D3, 91.5% declared treatment to be effective, 82.4% were satisfied with their treatment and 83.12% did not observe any side effects to the treatment. On D7, 95.9% declared treatment to be effective, 87.2% were satisfied with their treatment and 89.2% did not observe any side effects to the treatment. 9 out of 10 patients did not complain about side effects related to the treatment. CONCLUSIONS: A reduction in pain within the first 12 hours showed the pertinence of treatment using a paracetamol-codeine combination. This pertinence was confirmed by 2/3 patients who declared the treatment to be effective from the 1st day, and 91% of them declared this on the 3rd day
Conference/Value in Health Info
2011-11, ISPOR Europe 2011, Madrid, Spain
Value in Health, Vol. 14, No. 7 (November 2011)
Code
PSY50
Topic
Patient-Centered Research
Topic Subcategory
Patient-reported Outcomes & Quality of Life Outcomes
Disease
Systemic Disorders/Conditions